Clinical studies

Clinical trials are used to test the effectivity and safety of new methods or medicines. Participation in a study is always voluntary. Patients who participate in a study must fulfil the requirements defined for each study (inclusion and exclusion criteria).

If you are interested in participating in a clinical trial, please contact your attending physician. They have an overview of current studies for your disease and will inform you in detail.
 

An overview of current clinical studies at NCT/UCC can be found >>>here

With a specially founded unit, the Early Clinical Trial Unit, the NCT/UCC has specialised in conducting early clinical trials. In early clinical trials, a drug is tested on patients for the first time. Early clinical trials are particularly suitable for patients with advanced diseases for which no standard therapy is available. If you would like to learn more about participating in an early clinical trial, please contact us >>>here

Questions and answers

Although basically every patient can voluntarily participate in a clinical trial, not all trials are suitable for everyone. Since patient safety is top priority, so-called inclusion and exclusion criteria are defined in every study protocol. These regulate which patients are suitable for participation. The type of tumor disease, the stage of the disease and the type and number of previous tumor therapies play a role here. Furthermore, the patient's general physical health as well as laboratory parameters and previous illnesses are important.

Before you take part in a study, your physician will give you detailed information about the special features of the new drug, the course of the study treatment as well as possible risks. You will receive a detailed summary of all the information at home so that you can take your time while reading and discuss it with your relatives and your family doctor. Once all open questions have been clarified and you have decided to take part in the study, sign the consent form with your attending physician.

A key advantage of taking part in a trial is that you can benefit from early access to new medicines, which may have an impact on the course of your disease.

New or further developments of medicinal products always enter unknown territory and are accordingly associated with uncertainties. Your physician will inform you about known risks and observe you carefully during the treatment so that possible side effects can be recognised and treated in time.

If you have decided that you no longer wish to participate in the study, you can withdraw your consent at any time and without giving reasons. You will not face any disadvantages as a result.

Your treating investigator will first hold the educational interview and later the discharge interview with you. Furthermore, the investigator is responsible for your medical care and your safety during the study. In addition, organisational and administrative tasks will be carried out, for example cooperation with your family doctor.

Study nurses are responsible for the nursing, administrative and organisational tasks involved in conducting clinical trials. They are an important contact person for all participants in a study.

Your data will be recorded in a patient file. This contains all relevant medical information collected in connection with your study treatment. The medical staff involved in the study are bound by professional secrecy. Your data will therefore not be passed on to uninvolved third parties. However, it is necessary to forward your data anonymously (without mentioning your name) to the client for the purpose of evaluation.

With your signed consent to participate in the study, you have the right to be informed in detail by your attending physician about everything related to the study. Furthermore, you will get a so-called volunteer insurance as a study participant. This insurance will cover you if you suffer any damage to your health as a result of the study medication. Moreover, as already mentioned, you can withdraw your consent to participate in the study at any time. In the event that serious drug effects occur, your attending physician must discontinue the study therapy. As a study participant, you also have the right to a second medical opinion at any time.

By signing the consent form, you agree to the intended treatment. In order to detect risks in the course of the disease at an early stage, it is necessary for you to attend regular treatment and check-up appointments. It is important that you inform your study physician about all health changes and abnormalities. You should also inform your study physician if you are taking medication that is not part of your study medication. In the course of a clinical study, you will often have to answer questionnaires in which you have to comment on your state of health or keep a medication diary.

For more information on studies, take a look at the studies page, write us an email or give us a call. All contact information can be found on the contact page.